Big Pharma’s Future Profits to Come from Brazil, India and China

Just as the tobacco, food and beverage and automobile industries see their future in China, India and Brazil, a new report from IMS Institute for Healthcare Informatics finds that rising incomes among consumers in these emerging markets will drive global growth in pharmaceutical spending over the next five years. This is good news for the drug industry, which is struggling to maintain sales in the United States and Europe as patent expirations and price controls eat into profits.